Lysosomal inclusions in gastric parietal cells in mucolipidosis type IV: A novel cause of achlorhydria and hypergastrinemia

American Journal of Surgical Pathology

Volumn 23, Issue 12, 1999, Pages 1527-1531

  Lubensky, Irina A ^a   Schiffmann, Raphael ^b   Goldin, Ehud ^b   Tsokos, Maria ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

Atrophy; ECL cell hyperplasia; Gastric biopsy; Gastritis; Lysosomal storage disease; Mucolipidosis type IV

Indexed keywords

ACHLORHYDRIA; ADOLESCENT; ADULT; ARTICLE; ATROPHIC GASTRITIS; BIOACCUMULATION; CELL HYPERPLASIA; CELL INCLUSION; CELL VACUOLE; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; ENTEROCHROMAFFIN CELL; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERGASTRINEMIA; LYSOSOME; MALE; MUCOLIPIDOSIS; MUCOLIPIDOSIS TYPE 4; STOMACH BIOPSY; STOMACH PARIETAL CELL;

ACHLORHYDRIA; ADULT; BIOPSY; CHILD; CHILD, PRESCHOOL; ENTEROCHROMAFFIN-LIKE CELLS; FEMALE; GASTRIC FUNDUS; GASTRINS; GASTRITIS, ATROPHIC; GASTROSCOPY; HUMANS; HYPERPLASIA; INCLUSION BODIES; LYSOSOMES; MALE; MUCOLIPIDOSES; PARIETAL CELLS, GASTRIC;

EID: 0032759326     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000478-199912000-00010     Document Type: Article

References (25)

1. Amir N, Zlotogora J, Bach G. Mucolipidosis type IV: clinical spectrum and natural history. Pediatrics 1987;79:953-9.
2. Bargal R, Bach G. Mucolipidosis type IV: abnormal transport of lipids to lysosomes. J Inherit Melah Dis 1997;20:625-32.
3. Berman ER, Livni N, Shapira E, Merin S, Levij IS. Congenital corneal clouding with abnormal systemic storage bodies: a new variant of mucolipidosis. J Pediatr 1974;84:519-26.
4. Chitayat D, Meunier CM, Hodgkinson KA, et al. Mucolipidosis type IV: clinical manifestations and natural history. Am J Med Genet 1991;41:313-8.
5. Collen MJ, Ciarleglio CA, Stanczak VJ, Treem WR, Lewis JH. Basal gastric acid secretion in children with atypical epigastric pain. Am J Gastroenterol 1988;83:923-6.
6. Crandall BF, Philippart M, Brown WJ, Bluestone DA. Review article: mucolipidosis IV. Am J Med Genet 1982;12:301-8.
7. Creutzfeldt W. The consequences of hypergastrinemia. Yale J Biol Med 1994;67:181-94.
8. Euler AR, Byrne WJ, Campbell MF. Basal and pentagastrin-stimulated gastric acid secretory rates in normal children and in those with peptic ulcer disease. J Pediatr 1983;103:766-8.
9. Folkerth RD, Alroy J, Lomakina I, Skutelsky E, Raghavan SS, Kolodny EH. Mucolipidosis IV: morphology and histochemistry of an autopsy case. J Neuropathol Exp Neurol 1995;54:154-64.
10. Goldin E, Blanchette-Mackie EJ, Dwyer NK, Pentchev PG, Brady RO. Cultured skin fibroblasts derived from patients with mucolipidosis 4 are auto-fluorescent. Pediatr Res 1995;37:687-92.
11. Goutieres F, Arsenio-Nunes M-L, Aicardi J. Mucolipidosis IV. Neuropediatrics 1979;10:321-31.
12. Hammel I, Alroy J. The effect of lysosomal storage diseases on secretory cells: an ultrastructural study of pancreas as an example. J Submicrosc Cytol Pathol 1995;27:143-60.
13. Karasawa H, Tani N, Miwa T. The effect of omeprazole on ultrastructural changes in gastric parietal cells. Gastroenterol Jpn 1997; 23:1-8.
14. Livni N, Merin S. Mucolipidosis IV: ultrastructural diagnosis of a recently defined genetic disorder. Arch Pathol Lab Med 1978;102: 600-4.
15. Magee DF. Pyloric antral inhibition of gastrin release. J Gastroenterol 1996;31:758-63.
16. Modlin IM, Goldenring JR, Lawton GP, Hunt R. aspects of the theoretical basis and clinical relevance of low acid states. Am J Gastroenterol 1994;89:308-18.
17. Newman NJ, Starck T, Kenyon KR, Lessell S, Fish I, Kolodny EH. Corneal surface irregularities and episodic pain in a patient with mucolipidosis IV. Arch Ophthalmol 1990;108:251-4.
18. Prasad A, Kaye E, Alroy J. Electron microscopic examination of skin biopsy as a cost-effective tool in the diagnosis of lysosomal storage diseases. J Child Neurol 1996;11:301-8.
19. Schiffmann R, Dwyer N, Lubensky IA, et al. Constitutive achlorhydria in mucolipidosis type IV. Proc Natl Acad Sci U S A 1998; 95:1207-12.
20. Scott DR, Besancon M, Sachs G, Helander H. Effects of antisecretory agents on parietal cell structure and H/K-ATPase levels in rabbit gastric mucosa in vivo. Dig Dis Sci 1994;39:2118-26.
21. Tellez-Nagel I, Rapin I, Iwamoto T, Johnson AB, Norton WT, Nitowsky H. Mucolipidosis IV: clinical, ultrastructural, histochemical, and chemical studies of a case, including a brain biopsy. Arch Neurol 1976;33:828-35.
22. von Figura K. Molecular recognition and targeting of lysosomal proteins. Curr Opin Cell Biol 1991;3:642-6.
23. Weitz R, Kramer I, Nissenkorn I, Shapira Y, Ben-David E, Kohn G. Muscle involvement in mucolipidosis IV. Brain Dev 1990;12: 524-8.
24. Zeigler M, Bach G. Internalization of exogenous gangliosides in cultured skin fibroblasts for the diagnosis of mucolipidosis IV. Clin Chim Acta 1986;157:183-9.
25. Thompson IW, Day DW, Wright NA. Subnuclear vacuolated mucous cells: a novel abnormality of simple mucin-secreting cells of non-specialized gastric mucosa and Brunner's glands. Histopathology 1987;11:1067-81.